BPC-157 and TB-500 for Knee Pain
Most of what has been written about BPC-157 and TB-500 comes from early-stage laboratory research — which is what makes a 2021 paper out of Orlando stand out: it reports on real patients. Published in Alternative Therapies in Health and Medicine, the study reviewed the charts of people who had received BPC-157 — alone or together with thymosin beta-4 — injected directly into painful knees at a primary-care clinic. It is a published report in this pair’s literature, and the numbers it recorded are worth knowing.
View product →Findings
- A 2021 clinic study followed 16 patients who received BPC-157 injected directly into the knee for knee pain.
- 11 of 12 patients on BPC-157 alone reported significant relief.
- 3 of 4 who received BPC-157 together with TB-500 reported the same.
- Overall, 87.5% of patients said their knee pain improved.
- The authors recommend larger follow-up studies with before-and-after imaging.
The study, plainly stated
Lee and Padgett performed a retrospective chart review at the Institute for Hormonal Balance in Orlando, Florida, covering one year of records from 2019 to 2020. Seventeen patients had received an intra-articular injection of BPC-157 for knee pain — from osteoarthritis, meniscus tears, tendinosis, ligament injuries and other causes — and sixteen of them could be reached by phone, most between six months and a year after their injection. Patients were asked to rate their pain before the injection, how long the relief lasted, and how much the injection helped.
What it reported
- BPC-157 alone (12 patients): 11 of 12 — 91.6% — reported significant improvement in knee pain. One reported no improvement.
- BPC-157 + thymosin beta-4 (4 patients): 3 of 4 — 75% — reported significant improvement. One reported no relief.
- Overall: 14 of 16 patients — 87.5% — reported relief of their knee pain.
The authors concluded that the study “suggests that intra-articular injection of BPC-157 helps with multiple types of knee pain,” and called for future studies with follow-up MRI imaging to document the change behind the reported relief.
The authors frame it as grounds for larger imaging-backed follow-up studies. As published data on this pair goes, it is a rare and noteworthy entry.
What is thymosin beta-4 — and what is TB-500?
Thymosin beta-4 (Tβ4) is a 43-amino-acid protein found in nearly every cell in the body, with especially high concentrations in blood platelets and in the fluid of healing wounds. Its day job is binding actin — the structural protein cells use to move, divide and rebuild — which is why so much of its research literature sits in tissue-repair and cell-migration models. TB-500 is the research name for the synthetic version of thymosin beta-4 used in laboratory settings; when the Orlando paper says “TB4,” it is describing the same molecule researchers buy as TB-500. Our TB-500 guide covers the compound in more depth.
Why the two are studied together
BPC-157 — a fragment of a protein in gastric juice — and thymosin beta-4 come at tissue repair from different angles: BPC-157’s literature centres on blood-vessel formation and tendon-to-bone healing, while Tβ4’s centres on actin dynamics and cell migration. The overlap without redundancy is why the research community so often pairs them, a combination covered in our BPC-157 + TB-500 guide.
Vistara Labs stocks BPC-157 10 mg, TB-500 10 mg and a BPC-157 + TB-500 blend as lyophilised research materials, shipped from within Canada to every province.
Frequently asked questions
What did the 2021 knee-pain study actually find?
In a 16-patient retrospective chart review, 87.5% of patients reported relief of knee pain after intra-articular injection of BPC-157, alone or with thymosin beta-4. The authors recommend larger imaging-backed follow-up studies.
Is TB-500 the same thing as thymosin beta-4?
TB-500 is the research name for the synthetic version of thymosin beta-4, the actin-binding protein found in nearly all cells. Research papers typically write Tβ4 or TB4; supplier catalogues write TB-500.
Source: Lee E, Padgett B. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. Altern Ther Health Med. 2021 Jul;27(4):8-13. PMID 34324435.
